Table 1.
Patient demographics for frontal cortex and cerebellar brain samples included in this study.
| Mutation status | N | FTLD-TDP Type 1 | FTLD-TDP Type 2 | FTLD-TDP Type 3 | Male/Female | Mean age at death ± SD |
|---|---|---|---|---|---|---|
| PGRN + Cortex | 8 | 8 | n/a | n/a | 3/5 | 75.5 ± 10.1 (63-87) |
|
PGRN - Cortex |
32 | 12 | 11 | 9 | 18/14 | 74.9 ± 10.5 (52-97) |
|
PGRN + Cerebellum |
10 | 10 | n/a | n/a | 7/3 | 72.3 ± 10.3 (56-87) |
|
PGRN - Cerebellum |
30 | 12 | 12 | 6 | 16/14 | 73.8 ± 10.3 (52-97) |
* There was overlap of 6 PGRN+ and 25 PGRN- samples between the cerebellum and frontal cortex analyses. n/a = not applicable